Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA) ...Middle East

HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will...

Read More Details
Finally We wish PressBee provided you with enough information of ( Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA) )

Also on site :

• Julia Fox's Net Worth in 2025 Proves She's an It Girl
• Israel strikes Syria again, claims to have killed alleged Hamas member
• 'Full House' Star, 43, Makes Rare Comment About Ashley Olsen